2-indanylamino derivatives for the therapy of chronic pain

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/165 (2006.01) A61P 25/02 (2006.01) A61P 25/04 (2006.01)

Patent

CA 2470990

The present invention relates to the use of 2-indanylamino derivatives for the treatment of chronic pain. In particular, the invention relates to the use of 2-(2-indanylamino)-acetamide for the treatment of neuropathic pain, i.e. the pain associated with postherpetic neuralgia, trigeminal neuralgia, diabetic neuropathy and nerve distruction by the human immunodeficiency virus (HIV).

Cette invention a trait à l'utilisation de dérivés de 2-indanyl-amino pour traiter des douleurs chroniques. Elle porte, notamment, sur l'utilisation de la 2-(2-indanyl-amino)-acétamide pour le traitement des douleurs neuropathiques, c'est-à-dire des douleurs associées à des algies post-zostériennes, à des névralgies faciales, à la neuropathie diabétique et à la destruction des nerfs provoquée par le virus de l'immunodéficience humaine (VIH).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-indanylamino derivatives for the therapy of chronic pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-indanylamino derivatives for the therapy of chronic pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-indanylamino derivatives for the therapy of chronic pain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1951873

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.